Rhizomelic chondrodysplasia punctata type 3
MONDO:0010823Any rhizomelic chondrodysplasia punctata in which the cause of the disease is a mutation in the AGPS gene.
Also known as: AGPS deficiency, alkyldihydroxyacetonephosphate synthase deficiency, alkylglycerone-phosphate synthase deficiency, AGPS rhizomelic chondrodysplasia punctata, RCDP3, rhizomelic chondrodysplasia punctata caused by mutation in AGPS, rhizomelic chondrodysplasia punctata type 3, rhizomelic chondrodysplasia punctata, type 3
79 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsBroader categories
-
VR headsets tested as a possible treatment for blindness
Disease control TerminatedThis study tested whether using a virtual reality headset for one-hour sessions could help regenerate damaged optic nerves and improve vision in people with glaucoma or other retinal diseases. The idea came from promising results in rodents. However, the trial was terminated earl…
Phase: NA • Sponsor: Stanford University • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
Scientists gather leftover surgical tissue to unlock secrets of bone disease
Knowledge-focused TerminatedThis study collected bone, cartilage, skin, and fat tissue from 50 patients undergoing surgery at Children's National Medical Center. The goal was to grow cells from these tissues in the lab and analyze them to better understand bone and connective tissue diseases. The study was …
Sponsor: National Institute of Dental and Craniofacial Research (NIDCR) • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:52 UTC